236 related articles for article (PubMed ID: 32143185)
1. The protective effect of trusted dealers against opioid overdose in the U.S.
Carroll JJ; Rich JD; Green TC
Int J Drug Policy; 2020 Apr; 78():102695. PubMed ID: 32143185
[TBL] [Abstract][Full Text] [Related]
2. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
Carroll JJ; Marshall BDL; Rich JD; Green TC
Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
[TBL] [Abstract][Full Text] [Related]
3. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
[TBL] [Abstract][Full Text] [Related]
4. Use of rapid fentanyl test strips among young adults who use drugs.
Krieger MS; Goedel WC; Buxton JA; Lysyshyn M; Bernstein E; Sherman SG; Rich JD; Hadland SE; Green TC; Marshall BDL
Int J Drug Policy; 2018 Nov; 61():52-58. PubMed ID: 30344005
[TBL] [Abstract][Full Text] [Related]
5. High willingness to use rapid fentanyl test strips among young adults who use drugs.
Krieger MS; Yedinak JL; Buxton JA; Lysyshyn M; Bernstein E; Rich JD; Green TC; Hadland SE; Marshall BDL
Harm Reduct J; 2018 Feb; 15(1):7. PubMed ID: 29422052
[TBL] [Abstract][Full Text] [Related]
6. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
Moran L; Ondocsin J; Outram S; Ciccarone D; Werb D; Holm N; Arnold EA
Harm Reduct J; 2024 May; 21(1):92. PubMed ID: 38734643
[TBL] [Abstract][Full Text] [Related]
7. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
[No Abstract] [Full Text] [Related]
8. Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
Weitzman ER; Kossowsky J; Blakemore LM; Cox R; Dowling DJ; Levy O; Needles EW; Levy S
Clin Infect Dis; 2022 Aug; 75(Suppl 1):S98-S109. PubMed ID: 35579508
[TBL] [Abstract][Full Text] [Related]
9. Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.
Mistler CB; Chandra DK; Copenhaver MM; Wickersham JA; Shrestha R
J Community Health; 2021 Apr; 46(2):349-357. PubMed ID: 32997253
[TBL] [Abstract][Full Text] [Related]
10. The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths.
Yeo Y; Johnson R; Heng C
Mil Med; 2022 Aug; 187(9-10):244-247. PubMed ID: 34908134
[TBL] [Abstract][Full Text] [Related]
11. Health care and harm reduction provider perspectives on treating older adults who use non-medical opioids: a qualitative study set in Chicago.
Mason M; Post LA; Aggarwal R
BMC Health Serv Res; 2023 Aug; 23(1):876. PubMed ID: 37598163
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.
Goldman JE; Waye KM; Periera KA; Krieger MS; Yedinak JL; Marshall BDL
Harm Reduct J; 2019 Jan; 16(1):3. PubMed ID: 30621699
[TBL] [Abstract][Full Text] [Related]
13. Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia.
Mema SC; Sage C; Popoff S; Bridgeman J; Taylor D; Corneil T
Harm Reduct J; 2018 Apr; 15(1):19. PubMed ID: 29625621
[TBL] [Abstract][Full Text] [Related]
14. Insights from biosurveillance: non-fatal opioid overdoses in Rhode Island 2019-21.
King E; Marchetti L; Weidele H; Wolanski J; Shrestha N; St John K; Scagos R
Addiction; 2022 Sep; 117(9):2464-2470. PubMed ID: 35434861
[TBL] [Abstract][Full Text] [Related]
15. Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston.
Park JN; Sherman SG; Rouhani S; Morales KB; McKenzie M; Allen ST; Marshall BDL; Green TC
J Urban Health; 2019 Jun; 96(3):353-366. PubMed ID: 31168735
[TBL] [Abstract][Full Text] [Related]
16. Unintentional overdoses: understanding the fentanyl landscape and reducing harm.
Bell LA; Hadland SE
Curr Opin Pediatr; 2023 Aug; 35(4):408-414. PubMed ID: 36974444
[TBL] [Abstract][Full Text] [Related]
17. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
18. Guidance for Handling the Increasing Prevalence of Drugs Adulterated or Laced With Fentanyl.
Allen C; Arredondo C; Dunham R; Fishman M; Lev L; Mace S; Parks J; Rosa D; Shoyinka S; White D; Williams A
Psychiatr Serv; 2023 Oct; 74(10):1059-1062. PubMed ID: 37042103
[TBL] [Abstract][Full Text] [Related]
19. Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks.
Daniulaityte R; Silverstein SM; Getz K; Juhascik M; McElhinny M; Dudley S
Int J Drug Policy; 2022 Jan; 99():103463. PubMed ID: 34619443
[TBL] [Abstract][Full Text] [Related]
20. Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry.
Fredericksen RJ; Baker R; Sibley A; Estadt AT; Colston D; Mixson LS; Walters S; Bresett J; Levander XA; Leichtling G; Davy-Mendez T; Powell M; Stopka TJ; Pho M; Feinberg J; Ezell J; Zule W; Seal D; Cooper HLF; Whitney BM; Delaney JAC; Crane HM; Tsui JI
Harm Reduct J; 2024 Apr; 21(1):74. PubMed ID: 38561753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]